CLINICAL_TRIALS
trial_result
· 2023-10-23
Clinical Trial Update: Study to Assess Clinical Response of Duloxetine in Patients Hospitalized for Severe Depression [Phase 4]
Summary
Phase 4 trial update assessing duloxetine in hospitalized patients with severe depression has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boehringer Ingelheim | Conditions: Depressive Disorder, Major | Phase 4 | Status: COMPLETED | Results posted: 2023-10-23